> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Simplified Dosing for Cumberland’s Acetadote OK’d
- URL: https://www.fdaweb.com/simplified-dosing-for-cumberlands-acetadote-okd/
- Published: 2024-12-09T12:00:00.000Z
- Updated: 2026-09-14T14:48:54.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5158325

FDA has approved a Cumberland Pharmaceuticals supplemental NDA for a simplified dosing regimen of its Acetadote (N-acetylcysteine for injection) product. Acetadote is an intravenous formulation of N-acetylcysteine indicated to prevent or lessen liver injury after ingestion of potentially toxic quantities of acetaminophen.

“The newly approved dosing regimen simplifies the administration of Acetadote by combining the first two bags of the standard regimen into a single, slower infusion,” the company says. The streamlined approach has been used in hospitals and demonstrated to reduce the frequency of medication errors and potentially serious non-allergic anaphylactoid reactions.